Literature DB >> 1894590

Unexpected deaths in depressed medical inpatients treated with fluoxetine.

S A Spier1, M A Frontera.   

Abstract

BACKGROUND: Depression in the medically ill is underdiagnosed and undertreated. Fluoxetine would appear promising in this population because of its efficacy and benign side effect profile, but it has not been systematically studied in the medically ill.
METHOD: The authors report the cases of three seriously medically ill patients, seen in psychiatric consultation while patients on a general medical service, who were treated with fluoxetine for depression. Each was an elderly white female with pulmonary disease and atrial arrhythmias, including atrial fibrillation, and each was prescribed diuretics, nitrates, and other cardiac and/or pulmonary agents.
RESULTS: Each patient died within 10 days of beginning fluoxetine treatment, from unexplained causes.
CONCLUSIONS: The authors hypothesize that direct cardiac effects mediated by fluoxetine, or other factors, may have been contributory. The effects of fluoxetine on electrolytes, fluoxetine's possible effects on drug levels, and serotonin's effect on the pulmonary system are examined. Other antidepressant agents should be considered in this particular population until further data are available.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1894590

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  7 in total

Review 1.  Selective serotonin reuptake inhibitors in older patients. A tolerability perspective.

Authors:  U Skerritt; R Evans; S A Montgomery
Journal:  Drugs Aging       Date:  1997-03       Impact factor: 3.923

2.  Bradycardia associated with fluoxetine in an elderly patient with sick sinus syndrome.

Authors:  S Hussein; B M Kaufman
Journal:  Postgrad Med J       Date:  1994-01       Impact factor: 2.401

Review 3.  Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

Review 4.  Depression and its treatment in cardiac patients.

Authors:  F Fernandez
Journal:  Tex Heart Inst J       Date:  1993

Review 5.  Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.

Authors:  M G Harris; P Benfield
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

6.  Peripheral microvascular serotoninergic signaling is dysregulated in young adults with major depressive disorder.

Authors:  Jody L Greaney; Gabrielle A Dillon; Erika F H Saunders; Lacy M Alexander
Journal:  J Appl Physiol (1985)       Date:  2019-11-21

7.  A systematic review of depression and anxiety in patients with atrial fibrillation: the mind-heart link.

Authors:  Dimpi Patel; Nathaniel D Mc Conkey; Ryann Sohaney; Ashley Mc Neil; Andy Jedrzejczyk; Luciana Armaganijan
Journal:  Cardiovasc Psychiatry Neurol       Date:  2013-04-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.